Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Core EBITDA Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 102.84-36.0267.63-48.67-10.49

What is the latest Core EBITDA Growth ratio of NGL FINECHEM ?

The latest Core EBITDA Growth ratio of NGL FINECHEM is 102.84 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026102.84
Mar2025-36.02
Mar202467.63
Mar2023-48.67
Mar2022-10.49

How is Core EBITDA Growth of NGL FINECHEM Trending?

Years Core EBITDA Growth % Change
Mar2026 102.84
Positive
Mar2025 -36.02
Negative
Mar2024 67.63
Positive
Mar2023 -48.67
Negative
Mar2022 -10.49 -

Other Financial Ratios of NGL FINECHEM


Compare Core EBITDA Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,742.0 Cr -3.2% 4.8% 90% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-3.2%

4.8%

90%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses